PATENT CLAIM ANALYSIS

Application Number: 15939008
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "484000"]

Abstract:
This invention provides for biocompatible and biodegradable syringeable liquid, implantable solid, and injectable gel pharmaceutical formulations useful for the treatment of systemic and local disease states.

Claim (Index 8):
A liquid pharmaceutical composition consisting of about 10% (wt) dexamethasone dispersed in a triethyl ester of O-acetylcitric acid (TEAC).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.16
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13006801', '11236426', '13963574', '15017547', '12236877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8395051213094501
- 35 USC 102 Novelty (BERT): 0.5755023026636761
- Combined Prediction Score: 0.8131048394448728
- Mean Citation Score: 458.19889000000006
- Max Citation Score: 554.11237
- Similarity Product: 373.857084956829

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test